ResMed Earnings Per Share |
| RMD -- USA Stock | USD 108.81 0.39 0.36% |
The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
| Symbol | Refresh |
Earnings Per Share Analysis
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.ResMed |
| = | 1.99 times |
About Earnings Per Share
Earnings per Share is one of the most important measures of the current share price of a firm, and is used by investors to determine the company overall profitability; especially when it is compared to the EPS of similar companies.Compare to competitionAccording to company disclosure ResMed has Earnings Per Share of 1.99 times. This is 165.33% higher than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Earnings Per Share for all stocks is 13.48% higher than the company.
Peer Comparison
ResMed Earnings Per Share Comparison
ResMed is currently under evaluation in earnings per share category among related companies.
Current ResMed financial ratios
| Return On Equity | 15.68 % | ||
| Return On Asset | 9.58 % | ||
| Profit Margin | 13.52 % | ||
| Operating Margin | 28.58 % | ||
| Current Valuation | 15.35 B | ||
| Shares Outstanding | 142.74 M | ||
| Shares Owned by Insiders | 1.14 % | ||
| Shares Owned by Institutions | 64.13 % | ||
| Number of Shares Shorted | 3.76 M | ||
| Price to Earning | 55.05 times | ||
| Price to Book | 7.74 times | ||
| Price to Sales | 6.87 times | ||
| Revenue | 2.27 B | ||
| Gross Profit | 1.2 B | ||
| EBITDA | 649.65 M | ||
| Net Income | 307.39 M | ||
| Cash and Equivalents | 704.28 M | ||
| Cash per Share | 4.93 times | ||
| Total Debt | 810 M | ||
| Debt to Equity | 39.10 % | ||
| Current Ratio | 3.48 times | ||
| Book Value Per Share | 14.13 times | ||
| Cash Flow from Operations | 410.34 M | ||
| Short Ratio | 6.14 times | ||
| Earnings Per Share | 1.99 times | ||
| Price to Earnings To Growth | 2.64 times | ||
| Number of Employees | 6 K | ||
| Beta | 1.32 | ||
| Market Capitalization | 15.61 B | ||
| Total Asset | 3.26 B | ||
| Retained Earnings | 2.16 B | ||
| Working Capital | 781.73 M | ||
| Current Asset | 1.42 B | ||
| Current Liabilities | 637.99 M | ||
| Z Score | 11.4 | ||
| Five Year Return | 1.82 % | ||
| Last Dividend Paid | 1.4 |